Steven Holtzman, Biogen Idec on why Pharma investors should focus more on product than return

Описание: Established drug manufacturer Biogen Idec's Executive VP of Corporate Development's Steven Holtzman discusses the pessimism surrounding the possibility of creating sustainable companies instead of those for short term investment gain.

He calls for entrepreneurs who want to 'make a dent in the universe' and for them in particular, those companies that are creating world-changing drugs that can genuinely change people's lives.

We explore the ways that Steven believes companies should look to be operating in order to create these product-focused, long-term partnerships.